Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition184
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence82
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review63
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis60
Genetic heterogeneity of group A rotaviruses: a review of the evolutionary dynamics and implication on vaccination59
Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis58
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future57
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits56
Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation49
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials46
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review40
Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)39
The antifungal pipeline for invasive fungal diseases: what does the future hold?39
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status38
Is the world crippled by antimicrobial resistance, or simply lacking information?38
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice36
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?36
Computational analysis of target genes in monkeypox virus infection and potential therapeutic precursors35
Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs34
The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-1932
How can we tackle the overuse of antibiotics in low- and middle-income countries?31
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae31
Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience31
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects28
Neonatal ocular prophylaxis in the United States: is it still necessary?28
Health literacy, knowledge, household disposal, and misuse practices of antibiotics among UAE residents: a nationwide cross-sectional study27
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections27
Identification of antibiotic consumption targets for the management of Clostridioides difficile infection in hospitals- a threshold logistic modelling approach27
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials26
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections26
Visceral leishmaniasis elimination in India: progress and the road ahead25
Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens22
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China21
Monoclonal antibodies for the treatment of COVID-19 infection in children20
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age20
Molecular detections of coronavirus: current and emerging methodologies19
Building upon the core elements of antifungal stewardship: practical recommendations for effective antifungal stewardship in resource-limited settings19
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas18
New advances in the treatments of drug-resistant tuberculosis17
Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease17
Biosimilars as antivirals: opportunities and challenges17
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?16
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis16
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a16
Strategies to improve the diagnosis and clinical treatment of dermatophyte infections15
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies15
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation15
Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study15
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates15
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses14
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations14
Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China14
Understanding the genetic basis of immune responses to fungal infection14
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy14
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection13
Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections13
Clostridioides difficile infection in inflammatory bowel disease: a clinical review13
Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis13
Overcoming challenges in the management of recurrent urinary tract infections13
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs12
Therapeutic strategies to address monkeypox12
Improving management of febrile neutropenia in oncology patients: the role of artificial intelligence and machine learning12
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas 12
Therapeutic drug monitoring (TDM) in real-time: a need for the present future12
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better12
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy12
Evaluating diagnostic tools, outcome measures and antibiotic approach in diabetic foot osteomyelitis: a scoping review and narrative synthesis11
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex11
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin11
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study11
Potential activity of nanomaterials to combat SARS-CoV-2 and mucormycosis ‎coinfection‎11
Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications11
Alternative drugs for the treatment of gonococcal infections: old and new11
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan11
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge11
Effective antimicrobial therapies needed for treatment of severe infections in African newborns10
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin10
Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis10
New insights into the treatment of acute otitis media10
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?10
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision10
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis10
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study9
Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials9
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America9
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship9
How do we best manage Clostridioides difficle infections in the elderly?9
Langya henipavirus outbreak9
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers8
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies8
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability8
System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India8
The circadian rhythm of viruses and its implications on susceptibility to infection8
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain8
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria8
Effect of adalimumab interventions on general infection among adults: a systematic review and meta-analysis of randomized controlled trials8
From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B8
Evaluation of truenat assays for the diagnosis of pulmonary and extrapulmonary tuberculosis: a systematic review and meta-analysis8
Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex spe8
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents8
Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events7
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials7
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae7
Vitamin D receptor gene polymorphism and vitamin D supplementation on clinical/ treatment outcome in tuberculosis: current and future perspectives7
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China7
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR7207
How do we change our approach to COVID with the changing face of disease?7
Now that griseofulvin is not available, what to do with tinea capitis treatments?7
The rise of mucormycosis in Covid-19 patients in India7
An assessment of the index of rational drug prescribing for severe acute respiratory infections among hospitalised children in Northern Nigeria: a retrospective study7
Outpatient treatment options to address the SARS-CoV-2 variant Omicron7
Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis7
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)7
Gram-negative blood stream infections: prospects and challenges of rapid antimicrobial susceptibility testing7
Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients7
Waking up to the Naegleria threat: urgent measures needed to protect public health in Pakistan7
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis7
0.90506887435913